Plumbing the Core and Nibbling at the Margins of Cancer
Cancer Commons Contributing Editor George Lundberg, MD, is the face and curator of this invitation-only column
-
June 10, 2020
How I Cope with the Tsunami of Cancer and COVID-19 Info
With: Kevin Knopf, MD, MPHOncologists worldwide face the challenge of staying on top of the latest treatments, research findings, and other information that could help them treat their patients more effectively. Now, they must do so in the context of COVID-19. Here, our Curious… Read more »
-
May 20, 2020
How the Coronavirus Pandemic Impacts Cancer Care: Our Survey Results
With: Lola Rahib, PhDThe ongoing COVID-19 pandemic presents unprecedented challenges to cancer patients. Many have experienced changes to their care, and some face increased risk of infection or worse prognosis if they are infected. In partnership with the company xCures, Cancer Commons is… Read more »
-
April 27, 2020
The Challenges of Using Artificial Intelligence to Improve Cancer Treatment
With: Razelle Kurzrock, MDJeff Shrager, PhDIn a previous post, CureMatch co-founder Razelle Kurzrock, MD, told us all about her company’s artificial intelligence (AI) platform that matches patients with treatments based on their cancer’s molecular profile. Here, AI expert Jeff Shrager, PhD, responds, and Kurzrock offers… Read more »
-
April 3, 2020
How to Beat COVID-19 with Real-Time, Real-World Data
With: Mark Shapiro, PhDAs the COVID-19 pandemic continues, researchers around the world are working quickly to develop strategies to treat and prevent this disease. In partnership with the company xCures, Cancer Commons is studying how COVID-19 impacts cancer patients. Meanwhile, xCures has launched… Read more »
-
March 9, 2020
Facilitating Access to Treatment for Children with Brain Cancer
With:A Q&A with Leslie Jared, RN, MSN, Nurse Navigator at Cancer Commons. Email: leslie.jared@cancercommons.org Q: A midline glioma is a type of brain tumor that is particularly dangerous because of its nature and its location in the brain. It often… Read more »
-
March 2, 2020
Using Artificial Intelligence to Match Combination Targeted Therapies in Oncology
With: Razelle Kurzrock, MDA Q&A with Razelle Kurzrock, MD, Director of the Center for Personalized Cancer Therapy and the Rare Tumor Clinic at U.C. San Diego, and Co-Founder and Board Member of CureMatch, Inc. Email: razelle@curematch.com Q: The new understanding of many cancers… Read more »
-
February 21, 2020
Comprehensive Molecular Testing Needed for Stage IV Lung Cancer
With:A Q&A with David Spigel, MD, Chief Scientific Officer, Director of the Lung Cancer Research Program, and Principal Investigator at Sarah Cannon Research Institute. Email: dspigel@tnonc.com Q: You are an expert medical oncologist with particular interest in lung cancer. The… Read more »
-
November 4, 2019
Using Molecular Testing to Guide Treatment for Advanced Colorectal Cancer
With:A Q&A with Kalpana Kannan, PhD, former Scientist at Cancer Commons Q: Colorectal cancer is common, and although many cases in earlier stages are cured by surgery alone or with adjuvant chemotherapy, it is still a lethal threat for many… Read more »
-
October 7, 2019
Emphasizing Oncogeriatrics
With:A Q&A with Nicolò Matteo Luca Battisti, MD, Medical Oncologist at The Royal Marsden NHS Foundation Trust, London, United Kingdom, and Chair of the Young Interest Group of the International Society of Geriatric Oncology (SIOG); nicolo.battisti@gmail.com Q: Everyone knows that… Read more »
-
September 9, 2019
How to Treat Uveal Melanoma that Recurs in the Liver?
With: Emma Shtivelman, PhDA Q&A with Emma Shtivelman, PhD, Chief Scientist at Cancer Commons; emma@cancercommons.org Q: Malignant melanoma may arise from multiple sites, including the eye. What would you recommend be done for a 50-year-old man in the San Francisco Bay Area who… Read more »